Liberty Wealth Management’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
-1,207
| Closed | -$90K | – | 853 |
|
2021
Q3 | $90K | Buy |
1,207
+607
| +101% | +$45.3K | 0.03% | 310 |
|
2021
Q2 | $44K | Buy |
600
+4
| +0.7% | +$293 | 0.02% | 349 |
|
2021
Q1 | $40K | Hold |
596
| – | – | 0.02% | 325 |
|
2020
Q4 | $40K | Buy |
596
+4
| +0.7% | +$268 | 0.02% | 321 |
|
2020
Q3 | $37K | Buy |
592
+2
| +0.3% | +$125 | 0.02% | 281 |
|
2020
Q2 | $37K | Buy |
590
+4
| +0.7% | +$251 | 0.03% | 266 |
|
2020
Q1 | $32K | Buy |
586
+2
| +0.3% | +$109 | 0.03% | 275 |
|
2019
Q4 | $38K | Buy |
584
+26
| +5% | +$1.69K | 0.03% | 306 |
|
2019
Q3 | $32K | Buy |
558
+3
| +0.5% | +$172 | 0.03% | 315 |
|
2019
Q2 | $33K | Buy |
555
+3
| +0.5% | +$178 | 0.03% | 325 |
|
2019
Q1 | $33K | Buy |
552
+2
| +0.4% | +$120 | 0.02% | 270 |
|
2018
Q4 | $30K | Buy |
+550
| New | +$30K | 0.02% | 268 |
|